This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sangamo Therapeutics, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations by Shelley Q Wang
Introduction
Shelley Q Wang is an accomplished inventor based in Richmond, CA (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of rare genetic disorders. His innovative work has led to the development of a patent that addresses a critical health issue.
Latest Patents
Shelley Q Wang holds a patent titled "Method for the treatment of mucopolysaccharidosis type I." This patent describes methods and compositions for treating MPS I (Hurler/Hurler-Scheie/Scheie Syndrome) by administering a composition comprising an iduronidase (IDUA) polynucleotide. The invention aims to reduce, delay, and/or eliminate the need for additional treatment procedures, as well as the onset, progression, and severity of symptoms in subjects with MPS I.
Career Highlights
Wang is currently associated with Sangamo Therapeutics, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for genetic disorders.
Collaborations
Shelley Q Wang collaborates with notable colleagues, including Dale Ando and Cheryl Wong Po Foo, who contribute to the innovative environment at Sangamo Therapeutics, Inc.
Conclusion
Shelley Q Wang's contributions to biotechnology and his innovative patent for treating mucopolysaccharidosis type I highlight his commitment to improving patient outcomes. His work exemplifies the impact of dedicated inventors in the field of medical research.